US12458328B2 - Methods for delivery of bodily fluids onto a fibrous substrate - Google Patents
Methods for delivery of bodily fluids onto a fibrous substrateInfo
- Publication number
- US12458328B2 US12458328B2 US18/186,114 US202318186114A US12458328B2 US 12458328 B2 US12458328 B2 US 12458328B2 US 202318186114 A US202318186114 A US 202318186114A US 12458328 B2 US12458328 B2 US 12458328B2
- Authority
- US
- United States
- Prior art keywords
- substrate
- substrates
- blood
- fluid
- implementations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0038—Devices for taking faeces samples; Faecal examination devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0096—Casings for storing test samples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150053—Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
- A61B5/150061—Means for enhancing collection
- A61B5/150068—Means for enhancing collection by tissue compression, e.g. with specially designed surface of device contacting the skin area to be pierced
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150251—Collection chamber divided into at least two compartments, e.g. for division of samples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150343—Collection vessels for collecting blood samples from the skin surface, e.g. test tubes, cuvettes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150366—Blood collection bags, e.g. connected to the patient by a catheter comprising means for removing a small sample of collected blood from the bag
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2503/00—Evaluating a particular growth phase or type of persons or animals
- A61B2503/42—Evaluating a particular growth phase or type of persons or animals for laboratory research
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/18—Transport of container or devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/069—Absorbents; Gels to retain a fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
Definitions
- the disclosed technology relates generally to the collection of bodily fluids, and in particular, to the devices, systems, and methods providing for the collection, storage, dying and delivery of fluids in fibrous matrices or substrates.
- the devices, systems and methods disclosed here pertain to the delivery of blood or other bodily fluids onto substrates such as paper or fiber matrices in controllable volumes, the drying of blood onto the matrices, and the ability to transport the samples safely to remote analysis locations.
- Devices, systems and methods to collect bodily fluids are necessary devices for the growing field of personalized medicine. While analysis laboratories are well suited to perform diagnostic tests the collection of blood samples remains challenging, in particular for patients that do not have simple access to the blood testing laboratory. These patients can be located in rural areas, underserved sub-urban areas, or low resource areas and have significant barriers to accessing diagnostic services. In order to reach patients in any location and connect them with blood testing facilities; robust systems for sample encapsulation, stabilization, and shipping must be developed.
- Paper and fiber substrates have been utilized extensively to stabilize blood-based analytes such as viral RNA, antigens, and antibodies, and allow the transportation or bio-banking of blood samples.
- paper-based stabilization systems suffer from three main limitations: (1) the difficulty of transferring blood to the paper resulting in inconsistencies in the precision of the blood volumes and contamination of blood outside of the paper substrate, (2) the difficulty of quantifiably depositing and recuperating a known volume of blood, as the blood can wick into unpredictable shapes or suffer from variability in the placement, and (3) a challenge in handling and preparation of the imbibed paper for transportation, since contamination may still occur until the blood is actually dry.
- Example 1 the fluid collection system includes a fluid cartridge, including a housing including a lumen a connector; and at least one substrate disposed within the lumen, where the substrate is configured to be in fluidic communication with the connector so as to receive fluid from a fluid collection device.
- a fluid cartridge including a housing including a lumen a connector; and at least one substrate disposed within the lumen, where the substrate is configured to be in fluidic communication with the connector so as to receive fluid from a fluid collection device.
- Example 2 the system of Example 1 wherein the housing includes a plurality of interlocking housing portions.
- Example 3 the system of Example 1 wherein the interlocking portions include interlocking projections.
- Example 4 the system of Example 1 wherein the housing includes a plurality of tabs configured to secure the at least one substrate within the lumen.
- Example 5 the system of Example 1 wherein the tabs are fixedly attached to the interlocking housing portions.
- Example 4 the system of Example 1 wherein the housing includes a gasket disposed between the interlocking housing portions.
- Example 5 the system of Example 1 wherein the housing includes a removable cover secured over an opening.
- Example 6 the system of Example 1 wherein the removable cover is secured to the housing via adhesive.
- Example 7 the system of Example 1 wherein the at least one fluidic channel is an open microfluidic channel.
- Example 8 the system of Example 1 wherein the housing includes a connector configured to attach to a fluid collection device.
- Example 8 the system of Example 1 wherein the cartridge further includes an inlet configured to receive fluid from the fluid collection device via the connector.
- Example 9 the system of Example 1 wherein the further including an overflow reservoir.
- Example 10 the system of Example 1 wherein the at least one substrate includes two or more substrates disposed adjacently.
- Example 11 the system of Example 1 wherein the at least one substrate includes two or more substrates disposed separately.
- Example 12 the system of Example 1 wherein the at least one substrate includes a plurality of subunits.
- Example 13 the fluid collection system of Example 1 where the at least one substrate includes at least one reagent.
- Example 13 the fluid collection system of Example 1 further including an inlet in fluidic communication with the fluid collection device and at least one substrate.
- Example 13 the fluid collection system of Example 1 wherein the housing includes at least one vent.
- a fluid collection and storage cartridge including an interlocking housing defining a lumen; at least one fluidic channel; and at least one substrate, where the at least one substrate is disposed within the lumen and in fluidic communication with the at least one fluidic channel.
- Example 15 the cartridge of Example 14 wherein the at least one fluidic channel is an open microfluidic channel.
- Example 16 the cartridge of Example 14 wherein the housing includes a connector configured to attach to a fluid collection device.
- Example 17 the cartridge of Example 14 wherein the cartridge further includes an inlet configured to receive fluid from the fluid collection device via the connector.
- Example 18 the cartridge of Example 14 further including an overflow reservoir.
- Example 19 the cartridge of Example 14 wherein the at least one substrate includes two or more substrates disposed adjacently.
- Example 20 the cartridge of Example 14 wherein the at least one substrate includes two or more substrates disposed separately.
- Example 21 the cartridge of Example 14 wherein the at least one substrate includes a plurality of subunits.
- Example 22 the cartridge of Example 14 wherein the at least one substrate includes at least one reagent.
- the cartridge of Example 14 further including an inlet in fluidic communication with the fluid collection device and at least one substrate.
- Example 24 the cartridge of Example 14 wherein the housing includes at least one vent.
- a fluid collection system including a fluid collection device including at least one microfluidic channel; and a removable cartridge including a housing defining a lumen and containing at least one substrate, where the removable cartridge is configured to be detached from the fluid collection device for the drying and shipping of fluid contained by the at least one substrate.
- Example 26 the fluid collection system of Example 25 wherein the at least one substrate includes at least one reagent.
- Example 27 the fluid collection system of Example 25 further including an inlet in fluidic communication with the fluid collection device and at least one substrate.
- Example 28 the fluid collection system of Example 25 wherein the housing includes at least one vent.
- a collector comprises a housing that is placed onto the skin of the user and is able to collect blood and deliver it through a connector.
- the cartridge is appended to the collector through the connector and received the blood during the actuation of the collector.
- As blood is received by the cartridge it is dispatched onto a fibrous or paper substrate on which it can be dried.
- the cartridge may be detached for shipping simplicity.
- an integrated collection and containment device that collects and transfers the bodily fluid from a subject's tissue into an easily detachable tube or reservoir.
- Previous technologies approached the transfer of the bodily fluid in a linear manner: one device enabled the bodily fluid to exit the tissue and another device was used to collect the bodily fluid.
- the implementations disclosed herein simplify the process of bodily fluid collection by integrating the collection of the bodily fluid directly with the containment of bodily fluid within the same device.
- FIG. 1 A is a perspective view of the cartridge attached to a fluid collection device, according to one embodiment.
- FIG. 1 B is a perspective view of the device and cartridge of FIG. 1 A placed on the skin of a patient.
- FIG. 1 C is a perspective view showing the detachment of the collector of FIG. 1 A from the fluid collection device.
- FIG. 1 D is a schematic showing the transportation and analysis of fluid contained in the cartridge, according to one embodiment.
- FIG. 2 A is a perspective view of a collector containing paper matrices and an adhesive cover that can be removed to access the paper contained within, according to one adhesive.
- FIG. 2 B is a perspective view of the implementation of FIG. 2 A with the cover removed.
- FIG. 2 C is a perspective view of another embodiment of the cartridge having apertures disposed on the upper side and containing paper matrices and an adhesive cover that can be removed to access the paper contained within, according to one embodiment.
- FIG. 2 D is a perspective view of the implementation of FIG. 2 C with the cover removed.
- FIG. 3 A is a perspective view of another embodiment of the cartridge.
- FIG. 3 B is a perspective view of an alternate embodiment of the cartridge having apertures disposed on the upper side.
- FIG. 3 C is a perspective view of an implementation of the cartridge having an adhesive cover over the apertures.
- FIG. 3 D is a perspective schematic showing the insertion of a cartridge into a pouch or other container.
- FIG. 3 E is a perspective view of a cartridge having apertures that is configured to enable “punch out” removal of the substrates contained therein.
- FIGS. 4 A- 1 through 4 A- 4 are exploded views of a cartridge having removable upper and lower covers, according to one embodiment.
- FIGS. 4 B- 1 through 4 B- 4 are exploded views of a cartridge having interlocking housing portions, according to another embodiment.
- FIG. 5 A is a perspective view of the suspension of a substrate within the housing of a cartridge, according to one implementation.
- FIG. 5 B is a side view of the implementation of FIG. 5 A .
- FIG. 5 C is a perspective view of the suspension of a substrate within the housing of a cartridge, according to another implementation.
- FIG. 5 D is a side view of the implementation of FIG. 5 C .
- FIG. 5 E is a cross-sectional view of a substrate suspended within the housing according to one implementation.
- FIG. 5 F is a cross-sectional view of a substrate suspended within the housing according to another implementation.
- FIG. 5 G is a cross-sectional view of a substrate suspended within the housing according to yet another implementation.
- FIG. 5 H is an exploded cross-sectional view of one implementation of an interlocking housing securing a substrate therein.
- FIG. 5 I is a cross-sectional view of the housing implementation of FIG. 5 I with the housing portions interlocked.
- FIG. 6 A is a close-up perspective view of the junction and fluidic communication between the connector and a fluid collection device, according to one embodiment.
- FIG. 6 B is a perspective view of an inlet, according to one embodiment.
- FIG. 6 C is a perspective view of an inlet, according to another embodiment.
- FIG. 7 A is a top view of one embodiment of overlapping, adjacent substrates.
- FIG. 7 B is a top view of an alternate embodiment of a substrate having several subunits.
- FIG. 8 A is top view of adjacent substrates in fluidic communication with a microfluidic channel.
- FIG. 8 B is a top view of the implementation of FIG. 8 A , showing partial substrate saturation.
- FIG. 8 C is a top view of the implementation of FIG. 8 A , showing further substrate saturation, including the saturation of a second adjacent substrate.
- FIG. 9 is a graph showing the volume control ability of a cartridge containing multiple paper substrate(s) in which variable blood volumes are inputted.
- FIG. 10 A is a top view of the interior of the cartridge lumen having several spaced substrates connected by a microfluidic channel, according to one embodiment.
- FIG. 10 B is a further top view of the implementation of FIG. 10 A showing the sequential saturation of the substrates.
- FIG. 11 A is a top view of the interior of the cartridge lumen having several adjacent substrates and a reservoir, showing one embodiment for making precise aliquots of fluid onto substrates regardless of the volume inputted by absorbing the overflow onto the reservoir.
- FIG. 11 B is a top view of the interior of the cartridge lumen according to a further embodiment having several spaced substrates connected by a microfluidic channel and a reservoir.
- FIG. 12 A is a top view of the interior of the cartridge lumen having adjacent substrates containing different compositions and chemical additives for orthogonal clinical readouts, wherein the substrates are connected by a microfluidic channel, according to one embodiment.
- FIG. 12 B is a top view of the interior of the cartridge lumen having spaced substrates containing different compositions and chemical additives for orthogonal clinical readouts, wherein the substrates are connected by a microfluidic channel, according to one embodiment.
- FIG. 12 C is a perspective view of several spaced substrates in fluidic communication with an open microfluidic channel, according to one embodiment.
- FIG. 12 D is a top view of the interior of the cartridge lumen having spaced substrates of varying size, according to one embodiment.
- FIG. 13 A is a top view of the interior of the cartridge lumen having adjacent substrates and a microfluidic channel.
- FIG. 13 B is a side view of the interior of the cartridge lumen having adjacent substrates and a microfluidic channel, wherein the substrates are disposed so as to utilize gravity for preferential saturation of the substrates.
- FIG. 13 C is a top view of the implementation of FIG. 13 B , showing the sequential saturation of the substrates.
- FIG. 14 A is a top view of a substrate embodiment having a gap and a shunt.
- FIG. 14 B is a further top view of the implementation of FIG. 14 A showing saturation of the shunt.
- FIG. 14 C is a further top view of the implementation of FIG. 14 A showing bridging of the gap and initial saturation of the second substrate.
- FIG. 15 A is a top view of a substrate embodiment showing a method for plasma separation on the substrate in a cartridge with the ability to control the volume of plasma separated.
- FIG. 15 B is a further view of the implementation of FIG. 15 A , showing the saturation of the substrate with blood and plasma.
- FIG. 16 A is a top view of a series of treated substrates within the cartridge, according to one embodiment.
- FIG. 16 B is a side-by-side top view of an implementation of the substrates having preferential filling properties.
- FIG. 16 C is a top view of yet another implementation of the substrate disposed within the cartridge.
- the various embodiments disclosed or contemplated herein relate to a single device that can be used by untrained or minimally-trained persons to both collect bodily fluid and seamlessly deliver the sample onto a substrate, such as a paper or fiber matrix, for simple and robust transportation and stabilization of blood-based analytes.
- a substrate such as a paper or fiber matrix
- these embodiments allow for the sequential and measured collection of aliquots or fluid samples onto the substrate.
- an integrated or modular fluid collection device that is able to collect and transfer the bodily fluid from a subject's tissue into an easily detachable cartridge or collector.
- the collector contains substrate(s) for the absorption and drying of the collected fluid, and can be detached from the fluid collection device for easy transport to an off-site laboratory.
- Previous technologies approached the transfer of the bodily fluid in a linear manner: one device enabled the bodily fluid to exit the tissue and another device was used to collect the bodily fluid.
- the implementations disclosed herein simplify the process of bodily fluid collection by integrating the collection of the bodily fluid directly with the containment of bodily fluid within the same starting device.
- FIGS. 1 A, 1 B, 1 C and 1 D An exemplary embodiment of the system 5 comprising a fluid collection device 1 and a fluid collector or cartridge 10 is shown in FIGS. 1 A, 1 B, 1 C and 1 D .
- the device is used to puncture the skin of the subject and collect fluid, such as blood, which flows into the collector or cartridge 10 for storage and transport.
- the fluid collection devices 1 contemplated herein generally relate to devices, systems and methods for bodily fluids, such as those having an actuator—or “button”—at one end and at least one lancet disposed within the opposite end.
- an actuation mechanism when the button 1 A is depressed, an actuation mechanism is deployed—lancets extend to pierce the skin of a subject 2 for the collection of fluid and transport of the fluid into the cartridge 10 , such as via microfluidic channels disposed therein.
- the various embodiments disclosed of the cartridge 1 disclosed herein may be incorporated into or used with any of the fluid collection devices and systems 1 disclosed in co-pending U.S. application Ser. No. 13/949,108, filed Jul.
- FIGS. 1 A- 1 D depict an overview of the system 8 in use.
- the cartridge 10 is constructed so as to be capable of coupling to, or being provided with, a fluid collection device 1 , such as a blood collection device 1 (like those disclosed in co-pending U.S. application Ser. Nos. 13/949,108, 13/750,526, 14/816,994, 14/932,485 or 15/387,177).
- the fluid collection device 1 comprises an outflow device comprising an outflow channel 49 configured to shuttle fluid from the device 1 into the cartridge 10 .
- this coupling is achieved via a collar (shown at 6 ) disposed on a connector 18 , or other press-fitting techniques, such that it is possible to detach the cartridge 10 from the fluid collection device after filling, as is shown in FIG. 1 C . It is further understood that while in fluidic communication with the collection device 1 , fluid can exit the device via an outflow channel 49 disposed within an outflow tube 47 . Further discussion of this transfer is found below in relation to FIGS. 6 A- 6 C .
- the coupled fluid collection device 1 cartridge 10 unit (generally at 8 ) is placed on a patient 2 for collection so as to collect fluid onto a substrate 16 or substrates disposed within the cartridge 10 .
- the substrates 16 are collection or assay substrates 16 disposed within the cartridge 10 , and can be comprised of paper, fibrous matrices, or other porous material for the collection and drying of fixed quantities or aliquots of fluid, such as blood or other bodily fluid.
- the cartridge 10 can be easily inserted into clinical and laboratory equipment or workflows for diagnostics and/or biomarker detections.
- the various embodiments disclosed or contemplated herein relate to a cartridge 10 device that can be used by untrained or minimally-trained persons to both collect bodily fluid and seamlessly contain the bodily fluid, and related systems and methods.
- FIGS. 2 A- 2 B Various implementations feature a cartridge 10 containing one or more substrate(s) 16 therein for the collection and transport of collected fluid are shown in the implementations of FIGS. 2 A- 2 B .
- the cartridge 10 has a housing 12 with a central lumen 14 defined within the housing 12 .
- at least one substrate 16 is disposed within the lumen 14
- a coupling 18 or connector 18 is disposed at one end of the housing 12 that is constructed to be physically coupled to the fluid collection device for the intake of fluid into the cartridge 10 .
- the cartridge 10 has a cover 20 , such as a removable adhesive cover 20 disposed on one side 22 , such as a top side 22 , so as to provide for the sealing of the lumen 14 and subsequent removal of stored substrate(s) 16 .
- the cover 20 is a removable cover 20 that can be affixed to the side 22 by adhesive 24 so as to be capable of being removed when it is desirable to remove the substrate(s) 16 .
- the removable cover 20 can be removed—such as by “peeling,” as shown by reference arrow A in FIG. 2 A —to open the lumen 14 and expose the substrate 16 , as is shown in FIG. 1 B .
- the collector has thus 2 states; a closed airtight state, and an open state in which the paper or fibrous matrix contained within can be retrieved or dried.
- various other removable cover 20 implementations are possible. In certain circumstances, to avoid unwanted tampering and/or contamination, it is preferable that once the removable cover 20 is removed it cannot be easily replaced.
- apertures or vents 24 can be disposed on the cartridge 10 , for example on the top side 22 under the cover 20 .
- FIG. 1 C when the cover 20 is removed in these implementations, as shown by reference arrow A, the vents 24 are exposed (shown in FIG. 2 B ), allowing the flow of air into the lumen 14 to come into contact with the substrate (not shown).
- vents 24 can prevent contamination and/or tampering with the aliquots and substrate, as the vents can be sized to be smaller than a finger or other possible source of contamination.
- the cartridge 10 can be used to dry and transport the saturated substrates 16 with a variety of approaches.
- a cartridge 10 having first 22 and second 32 sides is provided.
- the first side 22 has an opening 22 A
- vents 24 are disposed on the second side 32 .
- Both sides 22 , 32 can be sealed with covers 20 .
- the vents 24 and covers 20 can prevent tampering and/or contamination of the sample, such as in at home use and during the transportation to a lab or other facility for analysis.
- the vents 24 have several side openings 24 A and a central opening 24 B. It is understood that alternate vent 24 configurations are of course possible.
- the cover 20 is removed after collection (shown at reference arrow A in FIG. 3 C ).
- the cartridge 10 is then placed in a sealed container 40 , such as a pouch 40 , as is illustrated by reference arrow B.
- the pouch 40 has a desiccant 42 .
- the desiccant 42 of these implementations is able to dry the substrate and sample during storage and transportation without contacting the fluid contained in the substrate.
- the substrate 16 can be removed from the cartridge 10 by inserting a rod 44 or other probe through the central vent opening 24 B, thereby urging the substrate 16 out the first side 22 opening 22 A, as is shown by reference arrow C. It is understood that in certain implementations, the first side opening 22 can be removed prior to removal, while in alternate implementations, the substrate 16 can be urged through the cover.
- the substrate(s) 16 can be suspended within the lumen 14 suspending the substrate 16 means that there are no unwanted channels or concave angles (also called “wedges”) adjacent to the substrate 16 where the liquid could be trapped or be diverted.
- the substrate 16 can be highly hydrophilic—such as a paper matrix—thereby enabling or driving capillary flow into the substrate 16 , while other aspects of the cartridge 10 and/or lumen 14 can be hydrophobic to prevent the accumulation of fluid or blood in unwanted areas.
- FIGS. 4 A- 5 I depict several implementations of the cartridge 10 having suspended substrate(s) 16 , though alternate implementations are of course possible. As described herein, these implementations can suspend the substrate 16 or substrates with minimal material covering either side of the substrate, yielding certain advantages. Several of these implementations are described herein, but as would be understood, further variations and implementations are contemplated for suspending the substrates within the lumen 14 with minimal contact.
- the cartridge 10 can be assembled with a bottom adhesive cover 20 A, substrates 16 , and a top adhesive cover 20 B.
- the cartridge 10 has a housing 12 with a central lumen 14 , connector 18 and several vents 24 , as has been previously described.
- the substrates 16 are disposed within the lumen via “clips” made up of tabs 54 , 56 .
- substrates 16 are disposed within the lumen 14 and secured in place via tabs or projections (as described below in relation to FIGS. 4 B- 1 through 5 I ), the housing 12 is able to be covered with the covers 20 A, 20 B to create a sealed chamber for the substrates 16 .
- an inlet 18 A is disposed within the connector 18 .
- This inlet 18 A is configured to be in fluidic communication with an attached fluid collection device (not shown) via a funnel 99 so as to shuttle fluid into the lumen 14 and saturate the substrate 16 , as is shown in FIGS. 6 A- 6 C .
- the inlet 18 A comprises a channel, such as an open microfluidic channel, as is discussed below, for example in relation to FIGS. 10 A- 10 B .
- the funnel 99 is in fluidic communication with the inlet 18 A, and in certain implementations the Spontaneous Capillary Flow (SCF) relationship is used for microfluidic channels within the funnel 99 so as to promote capillary flow into the inlet 18 A. In further examples, gravitational or other forces urge the fluid into the inlet and onto the substrate.
- SCF Spontaneous Capillary Flow
- the lower adhesive cover 20 A can be removed to promote drying of the fluid on the substrates 16 .
- the upper adhesive cover 20 B can be removed in order to allow the substrates 16 to be removed from the lumen 14 .
- the housing 12 has interlocking components and is configured to secure the substrate(s) 16 within the cartridge 10 so as to have minimal contact within the lumen 14 .
- FIG. 4 B- 1 to 4 B- 4 One such interlocking implementation is shown in FIG. 4 B- 1 to 4 B- 4 , where the substrate 16 is suspended within the housing 12 lumen 14 via an interlocking physical clamp formed by the housing components 12 A, 12 B. That is, in these implementations, the housing 12 consists of a first portion 12 A or lower housing 12 A and second portion 12 B or upper housing 12 B that are configured to engage, interlock or otherwise be fitted together to grasp or secure substrate(s) 16 within the lumen 14 defined by the housing 12 .
- the lower housing 12 B has one or more lower interlocking projections 15 or “catches” 15 disposed along the inner surface 14 A of the lumen 14 within the housing 12 .
- the upper housing 12 B comprises one or more paired upper openings 19 or “loops” 19 are disposed within the housing wall 12 C and are configured to interlock with the lower projections 15 , such that the loops 19 are configured to receive the corresponding opposite projections 15 , as would be understood by one of skill in the art.
- the upper and lower housings may comprise certain detent features (an example of which is shown in FIGS. 5 H- 5 I at 66 ) and therefore be interlocked or “snapped” in place to form a unitary housing 12 .
- the upper 12 B and lower 12 B housing portions may be secured to one another via other known methods.
- the lower housing 12 A contains a connector 18 having an inlet 18 A, certain implementations of which are described below in reference to FIGS. 6 A- 6 C .
- the lumen 14 of the lower housing 12 A is contoured 13 within to approximate the shape of the substrate(s) 16 disposed therein, as would be appreciated by one of skill in the art.
- the substrates 16 are suspended or “clipped” within the lumen 14 between lower supports 56 or tabs and upper supports or tabs 54 when the upper housing 12 B is fitted to the lower housing 12 A. That is, one or more tabs 56 or “clips” 56 are provided in the lower housing 12 A and disposed within the contours 13 . It is understood that these components can be formed within the walls of the housing 12 within the lumen, as described herein below.
- the projections 19 are configured to secure over the catches 15 , and the gasket 23 creates a substantially water- or air-tight seal between the components so as to suspend the substrates 16 within the sealed lumen 14 . That is, the substrates 16 are held in place by the physical clamping forces applied from the bottom clips 56 and top clips 54 . After fluid has been loaded into the substrates 16 , the loops 19 may be deflected or otherwise released from the catches 15 , thereby separating the lower housing 12 A from the upper housing 12 B and allowing for the removal of the substrates 25 .
- the substrate 16 according to these implementations is disposed and suspended within cartridge 10 in the lumen 14 . As shown in FIG. 5 A , the substrate 16 can be suspended within the lumen 14 to facilitate reliable transfer of the fluid to the substrate 16 , as would be appreciated.
- the substrate 16 is disposed within the collector lumen 14 so as to be in fluidic communication with a fluidic channel 50 , such as an open channel 50 having a channel opening 52 .
- a fluidic channel 50 such as an open channel 50 having a channel opening 52 .
- the open channel 50 can be any of the various channels described in the applications and patents incorporated by reference above, such as those that satisfy the SCF relationship, as has been previously described for example in U.S. application Ser. No. 13/949,108.
- the substrate 16 is thereby exposed to air on all sides, so as to facilitate accurate volume collection and drying.
- the substrate 16 need not be in physical contact with the channel 50 , so long as the substrate 16 is sufficiently proximal to the channel 50 , fluidic bridging can occur, thereby filling the substrate 16 .
- the open channel can be a microfluidic channel 50 having a U-shaped channel opening 52 A with the substrate 16 disposed adjacent to the open side, as shown in FIGS. 5 A and 5 B .
- the open channel 50 can be a “sandwich” channel opening 52 B shown in FIGS. 5 C and 5 D , where a portion of the substrate 16 is disposed within the “sandwich.”
- the channel opening 52 can comprise the channel geometry required to facilitate SCF.
- the ratio of the free perimeter (pf), defined by the length of the cross-section open to air or another medium, and the wetted perimeter (pw), defined by the length of the cross-section made up of solid hydrophilic material must be less than the cosine of the contact angle ( ⁇ ) of the fluid with the channel walls.
- the substrate 16 is suspended within the lumen 14 by projections, such as upper tabs 54 and/or lower tabs 56 which are affixed to the housing within the lumen 14 . It is understood that many configurations are possible, and that several upper tabs 54 A, 54 B and/or lower tabs 56 A, 56 B can be disposed within the lumen 14 , such that the substrate 16 can be suspended within the lumen 14 . It is understood that in certain implementations, the substrate can “click” into place between the tabs 54 , 56 , thereby improving the transfer fluid from a channel to the substrate 16 .
- the tensile strength of the substrate can provide sufficient spring force to retain the substrate in a fixed position between the various tabs 54 , 56 . It is also understood that in certain implementations, a spring (not shown) can be provided to urge the tabs 54 , 56 into a clasping position on either face of the substrate 16 .
- FIGS. 5 E- 5 I show further implementations for securing the substrate 16 within the housing 12 via projections, “clips” or tabs 54 , 56 disposed on either side of the lumen 14 and configured to secure the substrate(s) 16 .
- a single primary housing 12 contains bottom tabs 56 A, 56 B and top tabs 54 A, 54 B that are fixedly attached to the sides 12 C of the housing 12 within the lumen 14 .
- a substrate 16 may be introduced from above such that it is suspended between the bottom tabs 56 and top tabs 54 .
- a lower housing 12 A containing bottom tabs 56 A, 56 B configured to interface with a upper housing 12 B having top tabs 54 A, 54 B so as to secure the substrate 16 therein.
- the substrate 16 can be introduced between the bottom tabs 56 A, 56 B and top tabs 54 A, 54 B, such that when the lower housing 12 A and upper housing 12 B are interfaced together, the substrate 16 is held in place due to the clamping force between the bottom tabs 56 A, 56 B and top tabs 54 A, 54 B.
- substrate 16 may be adhered to a single primary housing 12 via a single tab 56 projected from the top or bottom 12 D of the housing 12 by way of adhesive 58 .
- the adhesive 58 can be a double-side tape with plastic backing, a transfer tape without a plastic backing, or a liquid adhesive.
- FIGS. 5 H- 5 I show cross-sectional side views of a device 10 assembly consisting of a lower housing 12 A and an upper housing 12 B.
- the lower housing 12 A contains bottom tabs 56 A, 56 B disposed within the lumen 14 , and features detent features or protrusions 66 disposed along on either side along the outer surface of the housing 12 . It is understood that these protrusions 66 enable the upper 12 B and lower 12 A portions of the housing to be snapped together.
- the upper housing 12 B of FIGS. 5 H- 5 I has paired top tabs 54 A, 54 B disposed with the lumen 14 .
- the housing 12 B further has sides 63 having openings 63 A therein and stops 65 , wherein the upper housing 12 B is thereby adapted to be capable of being snapped into place over the lower housing so as to prevent the removal of the upper housing 12 B from the lower housing 12 A, as would be readily appreciated.
- this catch mechanism (generally at 67 ) can thereby be used to secure the housing 12 together.
- a gasket 23 is also provided, as described above, such that in use when the lower housing 12 A is pressed together with the upper housing 12 B, the stops 65 temporarily deflect and then secure around the protrusions 66 to form the catch mechanism 67 . Accordingly, the gasket 23 compresses against the lower housing 12 A and the upper housing 12 B, creating an air- or water-tight seal, such that the substrate 16 is fixedly suspended within the lumen 14 for use.
- FIG. 6 A and FIGS. 6 B-C Further embodiments of the fluid collection device outflow channel 49 and corresponding inlet 18 A implementations are contemplated in FIG. 6 A and FIGS. 6 B-C .
- the coupling is achieved by way of a fitting on the connector 18 , which is also a “collar” 3 .
- the collar 3 can be pressure fit and include a rubber gasket, a thread, or a quarter turn lock.
- the connector 18 is therefore configured to couple directly with a fluid collection device 1 to create a fluidic and/or hermetic seal and facilitate the flow of fluid via the connector 18 into the cartridge 10 .
- the connector 18 of various implementations can contain an inlet (shown for example in FIGS.
- an outflow channel 49 can extend from an outflow tube 47 from the fluid collection device (as shown in relation to FIG. 1 C ).
- the outflow channel 49 extends from the outflow tube 47 such that the distal end of the channel 49 C is disposed within the connector 18 , thereby providing the initial transitional point for the flow of fluid 60 into the cartridge 10 .
- these outflow channels 49 contemplate outflow channel geometries that act as one-way flow valves. In this sense, the fluid 5 is able to flow by dripping into the cartridge 10 , but when the device 1 and cartridge 10 are inverted, the channel 49 will not allow backflow out of the tube. Many of these geometries are described in the incorporated reference U.S. application Ser. No. 14/816,994.
- FIG. 6 A features an outflow channel 49 having first 49 A and second 49 B channel edges which are in fluidic connection with the inner surface 6 of the connector 18 and/or the inlet 18 A. That is, the two channel edges 49 A, 49 B are in contact with the inner surface 6 of the inlet 18 A such that fluid 60 that flows out of the outflow channel 49 will come in contact with the inner surface 6 of the inlet lumen 84 .
- the fluid is able to flow out from the outflow channel 49 and into the inlet 18 A, and when it is rotated in the direction of reference arrow A fluid 60 is brought into contact with the inner surface 6 so as to fill the inlet reservoir, discussed in relation to FIGS. 6 B-C . It is understood that many other configurations are contemplated, as have been previously discussed.
- FIGS. 6 B- 6 C show two implementations for inlet 18 A designs for the application of fluid onto substrates 16 , as was shown in FIG. 4 A- 4 B .
- the inlet 18 A is in fluidic communication with the connector so as to accept the flow of fluid into the housing.
- the inlets 18 A- 1 , 18 A- 2 of these implementations have several sides 82 A, 82 B, 82 C abutting against a substrate 16 and defining an inlet lumen 84 .
- a distal plane 86 A is provided at the end of the lumen 84 proximal the interior of the housing.
- fluid 60 makes contact with a substrate 16 at a vertical wall (shown here at 82 A within the lumen 84 ).
- a vertical wall shown here at 82 A within the lumen 84 .
- any fluid that enters the inlet 18 A- 1 may only exit through the substrate 16 and components of the fluid may be filtered as the fluid flows down the length of substrate 16 .
- an alternate implementation of the inlet 18 A- 2 may instead have a gap 100 separating it from a substrate 16 .
- fluid may exit the inlet 18 A- 2 by flowing through the substrate 16 or by flowing through the gap 88 . It is understood that typically, fluid flows more quickly out of the inlet 18 A- 2 of FIG. 6 B than the inlet 18 A- 1 of FIG. 6 A , due to the presence of the gap 88 , with specific flow rate dependent on the size of gap 88 and the hydrophilicity of the inlet 18 A- 2 , as would be appreciated by a skilled artisan.
- the width 88 of the gap 88 is less than approximately 100 ⁇ m, the flow of fluid through gap 88 is minimal due to the effects of surface tension.
- the width 88 is greater than approximately 200 ⁇ m and less than approximately 400 ⁇ m, the majority of the fluid flows out of inlet 18 A- 2 through the gap 88 along the entire width of substrate 16 , as sufficient fluid must accumulate at gap 88 before the fluid has sufficient hydrostatic pressure to overcome the effects of surface tension.
- the fluid reaches distal regions of substrate 16 by first flowing down the outer surface of substrate 16 and then transporting within its fibers. Overall, the rate of filling of substrate 16 is increased when using inlets 18 A- 2 like those of FIG. 6 B as opposed to inlets 18 A- 1 without a gap 88 , as depicted in FIG. 6 A , and less filtering of fluid components within the substrate 16 .
- the filtering of red blood cells from whole blood occurs. It is further understood that when the distance of the gap 100 is greater than approximately 500 ⁇ m, the fluid is able to flow out of the inlet 18 A- 2 with minimal accumulation along the gap 100 . Thus, fluid is able to flow down the side or edge of the substrate 16 without covering its entire width, which can result in incomplete filling of substrate 16 . While the widths 100 A discussed above are relevant when the fluid used is whole blood and the width of the substrate is approximately 8 mm, the gap 88 distances used may vary in alternate implementations based on factors such as fluid viscosity, material surface properties, surface treatments, and the specific geometries of the inlet and the substrate.
- substrates 16 may consist of multiple discrete substrates 16 A, 16 B, 16 C, 16 D or a single continuous perforated strip 16 P comprising several subunits 16 P- 1 , 16 P- 2 , 16 P- 3 , 16 P- 4 .
- multiple round substrates 16 A, 16 B, 16 C, 16 D are arranged such that they are partially overlapping. It is understood that fluid is able to flow from one substrate to the next through regions of overlap. Substrates of alternate geometries such as ellipses or rectangles may also be used in place of round substrates.
- a single continuous substrate 16 P may be separated into subunits 16 P- 1 , 16 P- 2 , 16 P- 3 , 16 P- 4 by perforations 160 .
- the perforations 160 retain fluidic continuity during fluid collection, while allowing the substrate 16 to be broken apart into individual segments 16 P- 1 , 16 P- 2 , 16 P- 3 , 16 P following fluid collection.
- the perforated substrate 16 P need not be limited only to a rectangular geometry with rectangular components. For example, a single substrate 16 P made out of smaller perforated circular or ellipsoid segments may also be used.
- FIGS. 8 A, 8 B and 8 C certain implementations of the cartridge 10 facilitate the controlled, sequential filling of several substrates 16 A, 16 B.
- fluid 60 passing through the channel 50 (shown by reference arrow D) is able to come into contact with a first substrate 16 A (shown in FIG. 8 A ), flow into ( FIG. 8 B ) and eventually saturate 62 the substrate 16 A.
- a second substrate 16 B disposed adjacent to the first 16 A but opposite the channel 50 will begin filling after the first 16 A has become saturated such that the fluid has reach the intersection 64 between the substrates 16 A, 16 B. It is understood that the intersection 64 between the substrates 16 A, 16 B need not involve direct physical contact between the substrates 16 A, 16 B: the substrates 16 A, 16 B merely need to be disposed sufficiently proximally to allow for fluidic bridging between the first 16 A and second 16 B substrates. Further discussion of various implementations is found below, for example in relation to FIGS. 16 A-C .
- FIG. 9 This sequential saturation of the substrates 16 A, 16 B is demonstrated in FIG. 9 .
- controlled volumes of fluid were introduced into a collector having first (black circles) and second (white circles) substrates configured to be saturated at 50 ⁇ L were disposed substantially as shown in FIGS. 8 A- 8 C .
- the second substrate does not begin to fill until the first has reached the saturation point of approximately 50 ⁇ L.
- the substrates do not retain any additional fluid. Further discussion of excess fluid management is found below, for example in relation to FIGS. 10 A and 11 A . It is understood that the volumetric capacities of these components are correlated to surface area—in various implementations the capacity can be any size.
- the substrates 16 A, 16 B, 16 C are in fluidic communication with a channel 50 , such as an open channel satisfying the SCF relationship, as shown in the implementations of FIGS. 10 A- 10 B .
- a plurality of substrates 16 A, 16 B, 16 C are provided that are, in this embodiment, substrate(s) 16 A, 16 B, 16 C.
- substrates may be utilized, such as paper discs, glass fibers, foams, porous solids and other materials capable of sufficient capillary force to self-fill with liquid that is thus sequestered in the substrate.
- the substrate provides strong capillary force, thus allowing for self-filling so long as it is not in fluidic communication with another substrate with a stronger capillary force.
- a material of similar capillary force can be adjacent to it and will absorb the overflow.
- the substrate(s) 16 A, 16 B, 16 C are disposed within the housing (as shown variously above) so as to be in fluidic communication with and sequentially filled via the channel 50 , which in this implementation is an open microfluidic channel 50 having an opening 52 . It is understood that various channel 50 shapes and geometries may be utilized, and that certain implementations will result in spontaneous capillary flow along the channel 50 , as has been previously described in the incorporated references. It is further understood that in implementations having an opening 52 , the substrate(s) 16 A, 16 B, 16 C can be disposed adjacent to the opening 52 to facilitate fluid 60 transfer and/or bridging, as would be apparent to one of skill in the art.
- the substrate(s) 16 A, 16 B, 16 C are disposed in a linear orientation inside the housing.
- preferential saturation facilitates sequential saturation by the open channel 50 , as described herein.
- a first substrate 16 A is disposed adjacent to the proximal channel end 51 and a last substrate 16 C is disposed adjacent the distal end 53 .
- the capillarity of the substrate(s) 16 A, 16 B, 16 C in these implementations is greater than the capillarity of the open channel 50 , such that fluid 60 flowing into the collector (shown by reference arrow E) sequentially saturates each substrate 16 A sequentially (designated by I°, II°, and III°), prior to advancing distally through the channel 50 to subsequent substrate(s) 16 B, 16 C. It is understood that further numbers of substrates or substrate(s) can be provided.
- these implementations therefore allow for the preferential saturation of the proximal substrate 16 A prior to saturation of the subsequent substrate(s) 16 B, 16 C.
- sequentially saturation occurs because fluid 60 will preferentially enter the first substrate 16 A prior to saturation, at which point it will continue to flow through the channel 50 .
- an overflow reservoir 70 can be provided.
- the cartridge 10 has an overflow reservoir 70 , such as a sponge or high-absorbance paper 70 , though it is understood that various other substances or structures can be used as well.
- the overflow reservoir 70 is able to collect the additional fluid and prevent pooling within the housing.
- the assay substrates 16 A, 16 B can have fixed saturation volumes—for example 50 ⁇ L, 100 ⁇ L or 150 ⁇ L—while the overflow reservoir 70 can have a much larger saturation volume.
- the overflow reservoir can be used in conjunction with adjacent substrate(s) 16 A, 16 B, such as in the implementations of FIGS.
- the overflow reservoir 70 is used in conjunction with an open channel 50 and spaced substrate 16 A, 16 B configuration, like that of FIGS. 10 A and 10 B . It would apparent to one of skill in the art that further configurations are possible.
- a substrate 16 A can comprise a reagent 80 A, such as a blood lysis reagent, a nucleic acid stabilization reagent, a chaperone molecule to protect a specific blood analyte or other known reagents used in the clinical analysis of fluids such as blood or plasma: myriad examples are known.
- the reagent 80 A can be applied to one or more of the substrates 16 A prior to use, such that fluid 60 saturating the substrate 16 A is exposed to the reagent 80 A prior to drying and storage.
- FIG. 12 A three adjacent substrates 16 A, 16 B, 16 C are shown, but in additional implementations, other configurations are of course possible.
- the substrates 16 A, 16 B, 16 C are in fluidic communication with an open channel 50 .
- the downstream substrates 16 B, 16 C have been treated with reagents 80 B, 80 C.
- certain reagents 80 B, 80 C can be pre-applied to any or all of the substrates 16 A, 16 B, 16 C. It is understood that in certain circumstances it is beneficial to apply certain reagents 80 B, 80 C to downstream substrates 16 B, 16 C so as to prevent cross-contamination, as certain reagent may enter the fluid 60 and be carried down the channel 50 into a downstream substrate.
- the sequential filling of the substrates 16 A, 16 B, 16 C via a channel 50 facilitates substrate bypass, meaning the flowing fluid is not drawn toward a saturated substrate 16 A, instead passing by the saturated substrate 16 A to fill a subsequent substrate 16 B, 16 C with minor co-mingling or contamination from upstream substrate reagents.
- substrate bypass meaning the flowing fluid is not drawn toward a saturated substrate 16 A, instead passing by the saturated substrate 16 A to fill a subsequent substrate 16 B, 16 C with minor co-mingling or contamination from upstream substrate reagents.
- substrates 16 A, 16 B, 16 C, 16 D of various capacities can be distributed along the channel 50 for sequential saturation.
- certain implementations of the cartridge 10 can use gravity (shown generally with reference arrow G) to control the sequence of substrate 16 A, 16 B, 16 C saturation 62 from the channel 50 .
- gravity shown generally with reference arrow G
- the force of gravity combined with the capillarity of the substrates 16 A, 16 B, 16 C will lead to preferential fluid 60 saturation in a determined sequence, as is generally shown in FIG. 13 C .
- the substrate 16 can utilize selective fluidic bridging. That is, in certain implementations, a substrate 16 can be provided that has a first substrate portion 16 A and a second substrate portion 16 B disposed across a gap 90 . In certain of these implementations, a shunt 92 is also provided adjacent to, and in direct communication with the first substrate portion 16 A. In the implementations of FIGS. 11 A-C , the static substrate reservoir 19 is provided as a dogleg shunt 92 . Other implementations are possible.
- a second substrate portion 16 B is disposed “below” the first 16 A relative to gravity (G), and this second portion 16 B can act as an overflow reservoir.
- the initial flow of fluid 60 is in the direction of gravity (shown by reference arrow G).
- that additional fluid 60 A will begin to flow laterally (shown by reference arrow L) into the shunt 92 .
- FIG. 1 shows that the fluid reaches the gap 90 , that additional fluid 60 A will begin to flow laterally (shown by reference arrow L) into the shunt 92 .
- a fluidic bridge 61 can cross the gap 90 , so as to transfer additional fluid 60 into the second portion 16 B (reference arrow G 2 ).
- the fluid 60 A contained in the shunt 92 is therefore able to be static, such that additional fluid entering the substrate passes through the passes through the first substrate portion 16 A—bypassing the shunt 92 , when a specified volume of fluid 60 A is being held statically—so as to bridge 61 and enters the second substrate portion 16 B via the gap 90 .
- These implementations can be used to collect blood 60 A in the shunt 92 to present fluid exchanges or to soak excess fluid and control the fluid volume in the first substrate. As would be apparent to a skilled artisan, many configurations of these elements are possible.
- FIGS. 15 A- 15 B An alternate bridging substrate 16 is shown in the implementations of FIGS. 15 A- 15 B .
- the use of a separate second portion 16 B can provide overflow collection during the collection of plasma 60 A.
- the first portion 16 A is comprised of separation paper 16 A that preferentially allows plasma 60 A flow.
- blood 60 B is separated from plasma 60 A, in that plasma 60 A saturates the second end 96 prior to the arrival of blood 60 B.
- the second substrate end 96 can be selectively saturated with plasma 60 A, so that plasma 60 A is retained in that second end 96 , while blood 60 B remains in the first end longer and then selectively bridges 60 C to the second substrate portion 16 B as needed.
- the arrangement of the substrates and selection of substrate type and shape can allow the individual substrates to perform a variety of modular, or networked features and actions on blood flowing into the collector.
- the substrates can preferentially absorb blood, plasma or other fluids; transfer blood or other fluids with minimal volumes absorbed; apply a reagent or other treatment to the blood or fluid and/or filter the fluid blood. Additional features are also contemplated.
- FIG. 16 A three substrates 16 A, 16 B, 16 C are provided, with various reagents 80 A, 80 B being incorporated into the downstream substrates 16 B, 16 C, as has been previously described above.
- these networks of substrates can be modular in nature, and incorporate any number of variations depending on the assays of interest.
- the substrate pore size can be used to control the capillary pressure or force between the various substrates and thereby control fluid flow and saturation.
- a network comprising three substrates 16 A, 16 B, 16 C.
- the second substrate 16 B is an elongate paper channel 16 B of separation paper, as was discussed in relation to FIG. 15 A-B .
- the fluid enters the separation channel 16 B.
- the plasma 60 A proceeds faster than whole blood 60 , such that the third substrate 16 C is selectively saturated with plasma 60 A while the whole blood 60 is retained upstream, in the first substrate 16 A and the portion of the channel 16 B adjacent the first substrate.
- an additional overflow substrate 16 D is provided and disposed adjacent to the first 16 A.
- excess blood 60 can be directed into the overflow substrate while plasma saturates the third substrate 16 C.
- myriad additional combinations are possible.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Clinical Laboratory Science (AREA)
- Analytical Chemistry (AREA)
- Pain & Pain Management (AREA)
- Manufacturing & Machinery (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18/186,114 US12458328B2 (en) | 2016-09-21 | 2023-03-17 | Methods for delivery of bodily fluids onto a fibrous substrate |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662397751P | 2016-09-21 | 2016-09-21 | |
| US15/711,746 US11523805B2 (en) | 2016-09-21 | 2017-09-21 | Methods for delivery of bodily fluids onto a fibrous substrate |
| US17/186,483 US11622750B2 (en) | 2016-09-21 | 2021-02-26 | Methods for delivery of bodily fluids onto a fibrous substrate |
| US18/186,114 US12458328B2 (en) | 2016-09-21 | 2023-03-17 | Methods for delivery of bodily fluids onto a fibrous substrate |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/186,483 Continuation US11622750B2 (en) | 2016-09-21 | 2021-02-26 | Methods for delivery of bodily fluids onto a fibrous substrate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20240090880A1 US20240090880A1 (en) | 2024-03-21 |
| US12458328B2 true US12458328B2 (en) | 2025-11-04 |
Family
ID=61617628
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/711,746 Active 2039-04-03 US11523805B2 (en) | 2016-09-21 | 2017-09-21 | Methods for delivery of bodily fluids onto a fibrous substrate |
| US17/186,483 Active US11622750B2 (en) | 2016-09-21 | 2021-02-26 | Methods for delivery of bodily fluids onto a fibrous substrate |
| US18/186,114 Active US12458328B2 (en) | 2016-09-21 | 2023-03-17 | Methods for delivery of bodily fluids onto a fibrous substrate |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/711,746 Active 2039-04-03 US11523805B2 (en) | 2016-09-21 | 2017-09-21 | Methods for delivery of bodily fluids onto a fibrous substrate |
| US17/186,483 Active US11622750B2 (en) | 2016-09-21 | 2021-02-26 | Methods for delivery of bodily fluids onto a fibrous substrate |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US11523805B2 (en) |
| EP (1) | EP3515521B1 (en) |
| CN (2) | CN115844462A (en) |
| WO (1) | WO2018057760A1 (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013112877A1 (en) | 2012-01-25 | 2013-08-01 | Tasso, Inc. | Handheld device for drawing, collecting, and analyzing bodily fluid |
| EP4338669A3 (en) | 2014-08-01 | 2024-05-22 | Tasso, Inc. | Systems for gravity-enhanced microfluidic collection, handling and transferring of fluids |
| FI4035762T3 (en) | 2015-09-09 | 2023-12-04 | Drawbridge Health Inc | Devices for sample collection, stabilization and preservation |
| JP2019505282A (en) | 2015-12-21 | 2019-02-28 | タッソ インコーポレイテッド | Apparatus, system, and method for actuation and retraction in body fluid collection |
| CN108885209A (en) | 2016-04-22 | 2018-11-23 | 贝克顿·迪金森公司 | Multiple polymerizations dye device and its application method |
| EP3515521B1 (en) | 2016-09-21 | 2023-10-25 | Tasso, Inc. | Fluid cartridge for delivery of bodily fluids onto a fibrous substrate |
| GB2590814B (en) | 2017-01-10 | 2021-11-03 | Drawbridge Health Inc | Devices, systems, and methods for sample collection |
| JP7058662B2 (en) | 2017-02-08 | 2022-04-22 | ベクトン・ディキンソン・アンド・カンパニー | Dry dye reagent device, and how to manufacture and use it |
| CN111295138A (en) | 2018-09-14 | 2020-06-16 | 塔索公司 | Bodily fluid collection device and related method |
| CN117180836A (en) | 2018-11-13 | 2023-12-08 | 贝克顿·迪金森公司 | Dry reagent filter and methods of making and using the same |
| WO2021222066A1 (en) * | 2020-04-27 | 2021-11-04 | Tasso, Inc. | Devices for securely storing bodily fluids and associated systems and methods |
| US12048543B2 (en) | 2021-11-08 | 2024-07-30 | Satio, Inc. | Dermal patch for collecting a physiological sample with removable vial |
| US12053284B2 (en) | 2021-11-08 | 2024-08-06 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US12029562B2 (en) | 2021-04-14 | 2024-07-09 | Satio, Inc. | Dermal patch system |
| US12023156B2 (en) | 2021-10-13 | 2024-07-02 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US12214346B2 (en) | 2021-10-13 | 2025-02-04 | Satio, Inc. | Dermal patch with a diagnostic test strip |
| US12178979B2 (en) | 2021-10-13 | 2024-12-31 | Satio, Inc. | Dermal patch for delivering a pharmaceutical |
| US11877848B2 (en) | 2021-11-08 | 2024-01-23 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US11964121B2 (en) | 2021-10-13 | 2024-04-23 | Satio, Inc. | Mono dose dermal patch for pharmaceutical delivery |
| US11478175B1 (en) | 2021-10-20 | 2022-10-25 | Paulus Holdings Limited | Devices for collecting capillary blood and methods for same |
| US11957465B2 (en) | 2022-08-23 | 2024-04-16 | Reddrop Dx, Inc. | Accelerated ergonomic collection of capillary blood |
Citations (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6226378B1 (en) | 1993-11-02 | 2001-05-01 | Home Access Health Corporation | Method and system for anonymously testing for a human malady |
| US20010021536A1 (en) | 1998-09-18 | 2001-09-13 | Syntron Bioresearch, Inc. | Even fluid front for liquid sample on test strip device |
| EP1389443A1 (en) | 2002-08-12 | 2004-02-18 | Bayer Healthcare, LLC | Fluid Collecting and Monitoring Device |
| US20040197226A1 (en) | 1998-12-29 | 2004-10-07 | Flexsite Diagnostics, Inc. | Remote site urine collection device and method of use |
| US20050288605A1 (en) | 2002-11-18 | 2005-12-29 | Pellegrino Richard C | Bone marrow aspiration system |
| US20080243159A1 (en) | 2007-03-30 | 2008-10-02 | Stat Medical Devices, Inc. | Lancet device with combined trigger and cocking mechanism and method |
| US20090287237A1 (en) | 2006-07-18 | 2009-11-19 | Owen Mumford Limited | Skin pricking device |
| US20110124130A1 (en) | 2008-04-03 | 2011-05-26 | Peter Wagner | Device and method for analysis of samples with depletion of analyte content |
| EP2439540A2 (en) | 2009-06-02 | 2012-04-11 | Infopia Co., Ltd. | Sampling/sample-injecting apparatus and biodata-measuring set comprising same |
| EP2484448A1 (en) | 2011-02-03 | 2012-08-08 | Universite De Geneve | Non-card format devices for collecting, storing & analysing dried body fluid spots and related methods |
| US20130157381A1 (en) * | 2010-08-25 | 2013-06-20 | Concateno Uk Limited | Sample testing apparatus and method |
| US20130211289A1 (en) | 2012-01-25 | 2013-08-15 | Tasso, Inc. | Handheld Device for Drawing, Collecting, and Analyzing Bodily Fluid |
| WO2013191552A1 (en) | 2012-06-20 | 2013-12-27 | Fabpulous B.V. | Quick test device and method |
| WO2014088606A2 (en) | 2012-12-05 | 2014-06-12 | Theranos, Inc. | Systems, devices, and methods for bodily fluid sample collection and transport |
| US20140208836A1 (en) * | 2011-08-22 | 2014-07-31 | Waters Technologies Corporation | Analysis of dried blood spot samples in a microfluidic system with dilution of extracted samples |
| US20150080929A1 (en) | 2012-04-20 | 2015-03-19 | Medipurpose Pte. Ltd. | Lancet |
| US20150209068A1 (en) | 2014-01-28 | 2015-07-30 | Intrinsyk, LLC | Lancet Assembly |
| US20150305916A1 (en) | 2012-05-10 | 2015-10-29 | B. Braun Medical Sas | Ostomy appliance |
| WO2016074046A1 (en) | 2014-11-14 | 2016-05-19 | Axxin Pty Ltd | Biological sample collection and storage assembly |
| US20160331292A1 (en) | 2014-02-14 | 2016-11-17 | Htl-Strefa Spolka Akcyjna | A blocking mechanism for a patient's skin incision device and a method of controlling of a skin incision device by a blocking mechanism |
| WO2021076846A1 (en) | 2019-10-18 | 2021-04-22 | Tasso, Inc. | Plasma separation devices and related methods |
| US20210177383A1 (en) | 2016-09-21 | 2021-06-17 | Tasso, Inc. | Methods for delivery of bodily fluids onto a fibrous substrate |
| WO2021188594A1 (en) | 2020-03-18 | 2021-09-23 | Drawbridge Health, Inc. | Systems and methods for sample collection |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9119577B2 (en) * | 2006-03-01 | 2015-09-01 | Home Access Health Corporation | Specimen collection device |
| EP2030567A1 (en) * | 2007-08-31 | 2009-03-04 | Roche Diagnostics GmbH | Analytic device for detecting an analyte in a body fluid, cartridge for analytic device and method for creating a wound and examining the excreted body fluid |
| US20120277629A1 (en) * | 2011-04-29 | 2012-11-01 | Seventh Sense Biosystems, Inc. | Systems and methods for collection and/or manipulation of blood spots or other bodily fluids |
| MX365324B (en) * | 2013-03-15 | 2019-05-29 | Theranos Ip Co Llc | Methods and devices for sample collection and sample separation. |
| CA2909180C (en) * | 2013-04-15 | 2017-04-04 | Becton, Dickinson And Company | Biological fluid sampling device |
| US10779757B2 (en) * | 2014-08-01 | 2020-09-22 | Tasso, Inc. | Devices, systems and methods for gravity-enhanced microfluidic collection, handling and transferring of fluids |
| EP4338669A3 (en) * | 2014-08-01 | 2024-05-22 | Tasso, Inc. | Systems for gravity-enhanced microfluidic collection, handling and transferring of fluids |
| WO2016025709A1 (en) * | 2014-08-13 | 2016-02-18 | Oregon Health & Science University | Dried blood spot collection device |
-
2017
- 2017-09-21 EP EP17853907.8A patent/EP3515521B1/en active Active
- 2017-09-21 CN CN202211379095.3A patent/CN115844462A/en active Pending
- 2017-09-21 CN CN201780072026.9A patent/CN109996571B/en active Active
- 2017-09-21 WO PCT/US2017/052754 patent/WO2018057760A1/en not_active Ceased
- 2017-09-21 US US15/711,746 patent/US11523805B2/en active Active
-
2021
- 2021-02-26 US US17/186,483 patent/US11622750B2/en active Active
-
2023
- 2023-03-17 US US18/186,114 patent/US12458328B2/en active Active
Patent Citations (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6226378B1 (en) | 1993-11-02 | 2001-05-01 | Home Access Health Corporation | Method and system for anonymously testing for a human malady |
| US20010021536A1 (en) | 1998-09-18 | 2001-09-13 | Syntron Bioresearch, Inc. | Even fluid front for liquid sample on test strip device |
| US20040197226A1 (en) | 1998-12-29 | 2004-10-07 | Flexsite Diagnostics, Inc. | Remote site urine collection device and method of use |
| EP1389443A1 (en) | 2002-08-12 | 2004-02-18 | Bayer Healthcare, LLC | Fluid Collecting and Monitoring Device |
| US20050288605A1 (en) | 2002-11-18 | 2005-12-29 | Pellegrino Richard C | Bone marrow aspiration system |
| US20090287237A1 (en) | 2006-07-18 | 2009-11-19 | Owen Mumford Limited | Skin pricking device |
| US20080243159A1 (en) | 2007-03-30 | 2008-10-02 | Stat Medical Devices, Inc. | Lancet device with combined trigger and cocking mechanism and method |
| US20110124130A1 (en) | 2008-04-03 | 2011-05-26 | Peter Wagner | Device and method for analysis of samples with depletion of analyte content |
| EP2439540A2 (en) | 2009-06-02 | 2012-04-11 | Infopia Co., Ltd. | Sampling/sample-injecting apparatus and biodata-measuring set comprising same |
| CN102576031A (en) | 2009-06-02 | 2012-07-11 | 因福皮亚有限公司 | Sampling/sample-injecting apparatus and biodata-measuring set comprising same |
| US20130157381A1 (en) * | 2010-08-25 | 2013-06-20 | Concateno Uk Limited | Sample testing apparatus and method |
| EP2484448A1 (en) | 2011-02-03 | 2012-08-08 | Universite De Geneve | Non-card format devices for collecting, storing & analysing dried body fluid spots and related methods |
| US20140208836A1 (en) * | 2011-08-22 | 2014-07-31 | Waters Technologies Corporation | Analysis of dried blood spot samples in a microfluidic system with dilution of extracted samples |
| US20130211289A1 (en) | 2012-01-25 | 2013-08-15 | Tasso, Inc. | Handheld Device for Drawing, Collecting, and Analyzing Bodily Fluid |
| US20150080929A1 (en) | 2012-04-20 | 2015-03-19 | Medipurpose Pte. Ltd. | Lancet |
| US20150305916A1 (en) | 2012-05-10 | 2015-10-29 | B. Braun Medical Sas | Ostomy appliance |
| EP2863798A1 (en) | 2012-06-20 | 2015-04-29 | Fabpulous B.V. | Quick test device and method |
| CN104582571A (en) | 2012-06-20 | 2015-04-29 | 菲伯普鲁斯有限公司 | Quick test device and method |
| WO2013191552A1 (en) | 2012-06-20 | 2013-12-27 | Fabpulous B.V. | Quick test device and method |
| WO2014088606A2 (en) | 2012-12-05 | 2014-06-12 | Theranos, Inc. | Systems, devices, and methods for bodily fluid sample collection and transport |
| CN104968269A (en) | 2012-12-05 | 2015-10-07 | 赛拉诺斯股份有限公司 | Systems, devices and methods for bodily fluid sample collection, transport and processing |
| US20150209068A1 (en) | 2014-01-28 | 2015-07-30 | Intrinsyk, LLC | Lancet Assembly |
| US20160331292A1 (en) | 2014-02-14 | 2016-11-17 | Htl-Strefa Spolka Akcyjna | A blocking mechanism for a patient's skin incision device and a method of controlling of a skin incision device by a blocking mechanism |
| WO2016074046A1 (en) | 2014-11-14 | 2016-05-19 | Axxin Pty Ltd | Biological sample collection and storage assembly |
| US20210177383A1 (en) | 2016-09-21 | 2021-06-17 | Tasso, Inc. | Methods for delivery of bodily fluids onto a fibrous substrate |
| US11622750B2 (en) | 2016-09-21 | 2023-04-11 | Tasso, Inc. | Methods for delivery of bodily fluids onto a fibrous substrate |
| WO2021076846A1 (en) | 2019-10-18 | 2021-04-22 | Tasso, Inc. | Plasma separation devices and related methods |
| WO2021188594A1 (en) | 2020-03-18 | 2021-09-23 | Drawbridge Health, Inc. | Systems and methods for sample collection |
Non-Patent Citations (5)
| Title |
|---|
| Chinese First Office Action issued for Chinese Application No. 201780072026.9; Applicant: Tasso, Inc., Date of Mailing: Mar. 26, 2021, 7 pages. |
| Extended European Search Report received for EP Application No. 17853907.8; Applicant: Tasso, Inc, Date of Mailing: Apr. 9, 2020, 8 pages. |
| International Preliminary Report on Patentability received for PCT Application No. PCT/US2017/052754; Applicant: Tasso, Inc., Date of Mailing: Apr. 4, 2019, 7 pages. |
| International Search Report and Written Opinion received for PCT Application No. PCT/US17/52754; Applicant: Tasso, Inc., Date of Mailing: Nov. 29, 2017, 12 pages. |
| International Search Report and Written Opinion received for PCT Application No. PCT/US20/55916; Applicant: Tasso, Inc., Date of Mailing: Mar. 18, 2021, 11 pages. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109996571A (en) | 2019-07-09 |
| EP3515521C0 (en) | 2023-10-25 |
| CN115844462A (en) | 2023-03-28 |
| EP3515521A1 (en) | 2019-07-31 |
| CN109996571B (en) | 2022-11-29 |
| US20240090880A1 (en) | 2024-03-21 |
| WO2018057760A1 (en) | 2018-03-29 |
| EP3515521A4 (en) | 2020-05-13 |
| EP3515521B1 (en) | 2023-10-25 |
| US11622750B2 (en) | 2023-04-11 |
| US11523805B2 (en) | 2022-12-13 |
| US20210177383A1 (en) | 2021-06-17 |
| US20180078241A1 (en) | 2018-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12458328B2 (en) | Methods for delivery of bodily fluids onto a fibrous substrate | |
| US12121893B2 (en) | Pinch to open sample collection device | |
| US11358138B2 (en) | Fluid sample collection device | |
| AU2003215214B2 (en) | Fluid processing and control | |
| US11484877B2 (en) | Blood metering device with desiccant and support for storage media and inlay with flange | |
| US12186745B2 (en) | Fluidic system for taking in, dispensing and moving liquids, method for processing fluids in a fluidic system | |
| US20230398540A1 (en) | Simultaneous spot test and storage of blood samples | |
| US10463290B2 (en) | Biological sample collection and storage assembly | |
| TW202126261A (en) | Medium with hydrophobic patterns and break lines defining a blood collection volume | |
| EP3886701B1 (en) | Biological fluid sample collection device and method of using the same | |
| WO2019231837A1 (en) | Blood metering device with desiccant and support for storage media and inlay with flange |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
| AS | Assignment |
Owner name: TASSO, INC., WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MOGA, BEN;CASAVANT, BEN;BERTHIER, ERWIN;SIGNING DATES FROM 20190319 TO 20190624;REEL/FRAME:065015/0159 Owner name: TASSO, INC., WASHINGTON Free format text: ASSIGNMENT OF ASSIGNOR'S INTEREST;ASSIGNORS:MOGA, BEN;CASAVANT, BEN;BERTHIER, ERWIN;SIGNING DATES FROM 20190319 TO 20190624;REEL/FRAME:065015/0159 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |